← Back to Clinical Trials
Recruiting NCT06672107

NCT06672107 Driver Simulator Training to Improve Driving After Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06672107
Status Recruiting
Phase
Sponsor VA Office of Research and Development
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-11-17
Primary Completion 2029-06-30

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
Active Driver Training InterventionControl Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-11-17 with a primary completion date of 2029-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

One hundred Veteran stroke survivors will participate in both an Active Driver Training intervention and a Control intervention in a fully interactive driving simulator. In addition, all participants will complete pre- and post-intervention driving assessments in the driving simulator to measure driving performance and types of driving errors committed. Half the participants will receive the Active Driver Training first, whereas the other half will receive the Control intervention first. Each Active Driver Training session will provide targeted practice and feedback on each of four unique driving skills including: speed management, collision avoidance, lane positioning, and dashboard attention. The Control intervention will be matched for total time but will only provide extra familiarization with the operation of the driving simulator, with no skill-specific practice. It is predicted that the Active Driver Training Intervention will result in improved driving performance, relative to the Control condition. In addition, after a delay period of at least 6 months, all participants will be re-assessed in the driving simulator and will complete a survey to capture changes in driving status.

Eligibility Criteria

Inclusion Criteria: * U.S. Veterans * History of a unilateral stroke (at least 3 months post-onset) * Ages 40-80 * pre-morbidly right hand dominant * prior driving experience/U.S. driver's license Exclusion Criteria: * History of other neurologic illness (e.g., TBI, dementia, epilepsy, Parkinson's, etc.) * History of severe psychiatric illness (e.g., schizophrenia or other psychotic disorders) * Recent substance abuse/dependence disorder (\< 1 year) * Non-Veteran status

Contact & Investigator

Central Contact

Krista S Parker, PhD BA

✉ Krista.Parker@va.gov

📞 (925) 372-2513

Principal Investigator

Krista Schendel Parker, PhD BA

PRINCIPAL INVESTIGATOR

VA Northern California Health Care System, Mather, CA

Frequently Asked Questions

Who can join the NCT06672107 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06672107 currently recruiting?

Yes, NCT06672107 is actively recruiting participants. Contact the research team at Krista.Parker@va.gov for enrollment information.

Where is the NCT06672107 trial being conducted?

This trial is being conducted at Sacramento, United States.

Who is sponsoring the NCT06672107 clinical trial?

NCT06672107 is sponsored by VA Office of Research and Development. The principal investigator is Krista Schendel Parker, PhD BA at VA Northern California Health Care System, Mather, CA. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology